Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Andexanet Alfa in Healthy Japanese and Caucasian Subjects
NCT03310021Phase 2Completed
- Sponsor
- Portola Pharmaceuticals
- Start
- Aug 2017
- Primary completion
- Aug 2019
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of andexanet alfa in hemorrhage, sponsored by Portola Pharmaceuticals. Started Aug 2017; status: completed.
02
Drugs
andexanet alfa
03
Conditions
hemorrhage
Beyond the preview
Go deeper on NCT03310021.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03310021.